2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
08/25/17West Announces Fall Investor Conference Schedule
EXTON, Pa., Aug. 25, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September. Management will present at the Baird 2017 Global Healthcare Conference, at the InterContinental New York Barclay in New York, N.Y., at 3:10 p.m. EDT on Wednesday, September 6; the 201... 
Printer Friendly Version
07/27/17West Announces Second-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., July 27, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017. Second-Quarter 2017 Highlights Reported net sales of $397.6 million, a record high, grew 2.5% over the prior-year quarter. Net sales at constant currency (organic) grew by 3.9%. Second-... 
Printer Friendly Version
07/20/17West Announces Increase to Quarterly Dividend
West to Host Second-Quarter 2017 Conference Call EXTON, Pa., July 20, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has approved a fourth-quarter 2017 dividend of $0.14 per share, a 7.7% increase over the $0.13 per share declared for each of the four preceding quarters. This is the 25th consecutive annual increase in the Company's dividend. The ... 
Printer Friendly Version
06/01/17West Elects New Director to the Board
EXTON, Pa., June 1, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Deborah Keller as its newest member. With the addition of Ms. Keller, West's Board of Directors increases in size to 11 directors. Ms. Keller, 54, serves as a Principal at Black Frame Advisors, LLC, and recently retired as Chief Executive Officer of Covance Drug Development, a business segment of Laboratory Corp... 
Printer Friendly Version
05/30/17West to Present on Biologics Trends at InnoPack Pharma Confex
Presentation caps week-long series of educational seminars throughout India sharing scientific insights and best practices in drug containment and delivery for injectable biologics EXTON, Pa., May 30, 2017 /PRNewswire/ -- (Booth #B-3) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will deliver a presentation on best practices for improving patient outcomes through integrated containment a... 
Printer Friendly Version
05/15/17West Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
EXTON, Pa., May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as of July 19, 2017. The Company also announced that management will be presenting an overview of the business at three investor conferences in May and June. Management will present at the... 
Printer Friendly Version
05/03/17West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings
EXTON, Pa., May 3, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio, Vice President Scientific Affairs and Technical Services, and Diane Paskiet, Director, Scientific Affairs, are leading several workshops and offering presentations focused on West's expertise in the areas of safety and compatibility of injectable products, as well as providing commentary on updated ... 
Printer Friendly Version
04/27/17West Announces First-Quarter 2017 Results
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., April 27, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017.  First-Quarter 2017 Highlights Reported net sales of $387.7 million grew 7.1% over the prior-year quarter. Net sales at constant currency grew by 8.7%. First-quarter 2017 reported-dilu... 
Printer Friendly Version
04/13/17West to Host First-Quarter 2017 Conference Call
EXTON, Pa., April 13, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday, April 27, 2017, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International)... 
Printer Friendly Version
02/16/17West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend
- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa., Feb. 16, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017.  Executive Summary Fourth-quarter 2016 reported net sales of $382.3 million grew 6.3% over the prior-year quarter.  At constant currency, organic sales growth was 7.7%. ... 
Printer Friendly Version
02/02/17West to Host Fourth-Quarter and Full-Year 2016 Conference Call
EXTON, Pa., Feb. 2, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens on Thursday, February 16, 2017, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738... 
Printer Friendly Version
02/01/17West Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe
Scientific and educational sessions to feature West's innovation and regulatory expertise EXTON, Pa., Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced two new offerings at Pharmapack Europe 2017. The LyoSeal® cap, an all-plastic, instant sealing solution for lyophilized drug products, is designed to minimize risk associated with established lyophilization p... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations